Ariane Beauvais
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Peripheral defects precede neuromuscular pathology in the Smn2B/- mouse model of spinal muscular atrophy.
Journal: Journal of neuromuscular diseases
Published: February 20, 2025
Modulation of miR-145 in a mouse model of multiple sclerosis: A promising approach to attenuate inflammation and degeneration.
Journal: Neurobiology of disease
Published: February 18, 2025
Liver SMN restoration rescues the Smn2B/- mouse model of spinal muscular atrophy.
Journal: EBioMedicine
Published: May 14, 2024
Long term peripheral AAV9-SMN gene therapy promotes survival in a mouse model of spinal muscular atrophy.
Journal: Human molecular genetics
Published: August 31, 2023
Base editing as a genetic treatment for spinal muscular atrophy.
Journal: bioRxiv : the preprint server for biology
Published: January 30, 2023
Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophy.
Journal: Nature biomedical engineering
Published: January 21, 2023
Suppression of the necroptotic cell death pathways improves survival in Smn 2B/- mice.
Journal: Frontiers in cellular neuroscience
Published: June 17, 2022
Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy.
Journal: Gene therapy
Published: January 21, 2022
SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease.
Journal: Cellular and molecular gastroenterology and hepatology
Published: May 04, 2020
Blood Flow to the Spleen is Altered in a Mouse Model of Spinal Muscular Atrophy.
Journal: Journal of neuromuscular diseases
Published: April 26, 2020
Last Updated: 09/26/2026